GSK doubles down on oncology with $10.6bn Nuvalent takeover
GSK will acquire lung cancer biotech Nuvalent for $10.6bn in one of its largest ever deals, bolstering its…
National Grid agrees to pay £20m after failing to maintain assets
National Grid has agreed to pay £20m into a regulatory redress scheme after admitting failures to properly monitor…